Edwards Lifesciences Corporatio vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
7.2
Bullish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
EW
Clean balance sheet with low leverage (0.1× debt-to-equity).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $97.15 (+15.7%)
27 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
EW
PFE
45.4×
Trailing P/E
19.4×
25.0×
Forward P/E
9.4×
17.4%
Profit Margin
12.4%
77.9%
Gross Margin
75.8%
—
ROE
8.9%
16.7%
Revenue Growth
-1.2%
8.2%
Earnings Growth
—
0.94
Beta
0.39
—
Price / Book
—
$48.4B
Market Cap
$149.8B
$72 – $88
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →